December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Immunogen Inc (NQ: IMGN )

7.210 USD -0.370 (-4.88%)
Official Closing Price Updated: 7:19 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Immunogen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags APRE Market News LIFE
From Benzinga
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
From Business Wire News Releases
ImmunoGen Announces Webcast of Presentation and Q&A at the 39th Annual J.P. Morgan Healthcare Conference
ImmunoGen Announces Webcast of Presentation and Q&A at the 39th Annual J.P. Morgan Healthcare Conference 
From Business Wire News Releases
82 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares surged 60.4% to close at $24.60 on Monday. Nantkwest Inc ... 
Tags LMT GTT CLSK
From Benzinga
Stocks That Hit 52-Week Highs On Friday
Friday's session saw 466 companies set new 52-week highs. Key Facts: Tesla (NASDAQ: TSLA) was the company with ... 
Tags AHCO Electrical Components & Equipment NVST
From Benzinga
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PTCT MNKD LEGN
From Benzinga
ImmunoGen Presents Updated Findings from Phase 1/2 Study of IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm at ASH Annual Meeting
ImmunoGen Presents Updated Findings from Phase 1/2 Study of IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm at ASH Annual Meeting 
From Business Wire News Releases
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
From Business Wire News Releases
ImmunoGen Announces Conference Call to Discuss Recent Updates for IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukemia
ImmunoGen Announces Conference Call to Discuss Recent Updates for IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukemia 
From Business Wire News Releases
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ... 
Tags BNTX LQDA Small Cap
From Benzinga
Interesting IMGN Put And Call Options For July 2021
Investors in ImmunoGen, Inc. (IMGN) saw new options become available this week, for the July 2021 expiration.. 
Tags Stocks
From Market News Video
ImmunoGen Announces Webcasts of Presentations at Upcoming Virtual Conferences
ImmunoGen Announces Webcasts of Presentations at Upcoming Virtual Conferences 
From Business Wire News Releases
Recap: Immunogen Q3 Earnings
Shares of Immunogen (NASDAQ:IMGN) rose 3.3% in pre-market trading after the company reported Q3 results. Quarterly ... 
Tags Market News Benzinga IMGN
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags HRMY News ZBH
From Benzinga
ImmunoGen Reports Recent Progress and Third Quarter 2020 Financial Results
ImmunoGen Reports Recent Progress and Third Quarter 2020 Financial Results 
From Business Wire News Releases
Earnings Scheduled For November 6, 2020
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly earnings at ... 
Tags VIRT GNE SSP
From Benzinga
Earnings Outlook for Immunogen
On Friday, November 06, Immunogen (NASDAQ:IMGN) will release its latest earnings report. Benzinga's outlook for Immunogen is ... 
Tags Market News IMGN Benzinga
From Benzinga
ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual London Healthcare Conference
ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual London Healthcare Conference 
From Business Wire News Releases
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
From Business Wire News Releases
Why that hot stock in your portfolio might be no better than a lottery ticket
More gambling goes on in the stock market than in all the world’s casinos combined. 
Tags NFLX AMRN AGEN
From MarketWatch
Week In Review: Fosun's Gland Pharma Approved For $814 Million IPO In India
India's Gland Pharma, a majority-owned subsidiary of Shanghai Fosun Pharma, was approved for an $814 million IPO on India's Sebi exchange (see story). The Hyderabad-based drug company makes generic... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Week in Review: Fosun's Gland Pharma Approved for $814 Million IPO in India
Deals and Financings   India 's Gland Pharma, a Shanghai Fosun subsidiary, was approved to conduct an $814 million IPO in India to support its injected drug portfolio; Huadong Medicine in-licensed... 
From ChinaBio® Today
Week in Review: Fosun's Gland Pharma Approved for $814 Million IPO in India
Deals and Financings   India 's Gland Pharma, a Shanghai Fosun subsidiary that specializes in generic injected drugs, was approved to conduct an $814 million IPO in India ; Huadong Medicine in-licensed... 
From ChinaBio® Today
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2020 Operating Results
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2020 Operating Results 
From Business Wire News Releases
Tuesday's ETF Movers: TAN, XBI
In trading on Tuesday, the Invesco Solar ETF is outperforming other ETFs, up about 4.2% on the day. Components of that ETF showing particular strength include shares of Daqo New Energy, up about 11.8%... 
Tags ETFs
From ETF Channel
ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China
ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China 
From Business Wire News Releases
Huadong Med Acquires ADC for Ovarian Cancer in $305 Million Agreement
Huadong Medicine in-licensed greater China rights to an antibody-drug conjugate developed by ImmunoGen in a $305 million agreement. IMGN853 (mirvetuximab soravtansine) is in a US Phase III trial for... 
From ChinaBio® Today
ImmunoGen Raises $54.8 Million in Gross Proceeds Through its At-the-Market Facility
ImmunoGen Raises $54.8 Million in Gross Proceeds Through its At-the-Market Facility 
From Business Wire News Releases
Are These The Best Penny Stocks To Buy Now Or Should You Wait?
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Add Up The Pieces: LABU Could Be Worth $93
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.